The relationship of frequency of cocaine use to substance and psychiatric disorders in the US general population
E Aharonovich, J Scodes, MM Wall, DS Hasin - Drug and alcohol …, 2021 - Elsevier
Background In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
The relationship of frequency of cocaine use to substance and psychiatric disorders in the US general population.
E Aharonovich, J Scodes, MM Wall… - Drug and Alcohol …, 2021 - europepmc.org
Background In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
The relationship of frequency of cocaine use to substance and psychiatric disorders in the US general population.
E Aharonovich, J Scodes, MM Wall, DS Hasin - 2021 - cabidigitallibrary.org
Background: In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
The relationship of frequency of cocaine use to substance and psychiatric disorders in the US General population.
E Aharonovich, J Scodes, MM Wall… - Drug and Alcohol …, 2021 - psycnet.apa.org
Background: In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
The relationship of frequency of cocaine use to substance and psychiatric disorders in the US general population
E Aharonovich, J Scodes… - Drug and alcohol …, 2021 - pubmed.ncbi.nlm.nih.gov
Background In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
[HTML][HTML] The relationship of frequency of cocaine use to substance and psychiatric disorders in the US general population
E Aharonovich, J Scodes, MM Wall… - Drug and alcohol …, 2021 - ncbi.nlm.nih.gov
Background In clinical trials of pharmacotherapy for substance use, abstinence is the
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …
primary endpoint accepted by regulatory agencies. However, this endpoint could be overly …